Kineticos Senior Team Decades of Experience, Trusted Knowledge
At Kineticos, our senior team consists of life sciences industry professionals with decades of combined experience and highly-diversified backgrounds. With a wealth of knowledge gained from this extensive life science experience, Kineticos delivers significant value to a range of clients seeking trusted strategy consulting services. Below, you will find information and details about the backgrounds, education, and industry experience of our leadership team members.
Mr. Maingi founded Kineticos Life Sciences in 2012 and develops long-term and day-to-day execution strategies.
In addition to serving as CEO of Kineticos, Mr. Maingi is as a Board Observer for Locus BioSciences, a CRISPR gene editing start-up. Mr. Maingi also served on the Board of Directors at Gallus Biopharmaceutical, a biopharmaceutical CMO, and on the Advisory Boards of Novolipid and Enci Therapeutics, two pre-clinical oncology biotechnology start-ups. Mr. Maingi is currently on the Board of Directors at Prevention Partners, a Chapel Hill, NC based non-profit. In addition, Mr. Maingi is Adjunct Faculty at the UNC’s Kenan-Flagler School of Business.
Prior to founding Kineticos Life Sciences, Mr. Maingi was a senior executive at Cardinal Health/PTS and Sigma-Aldrich/Supelco. Mr. Maingi earned a BS in Chemistry from UNC, Chapel Hill and an MBA from Golden Gate University.
Mr. Maingi’s Areas of Expertise:
Corporate Strategy and Execution
Research and Innovation
Business and Corporate Development
Process Improvement / Change Management
Mr. Osterman, Senior Vice President of Kineticos’ Biopharmaceutical Practice, adds more than 25 years of experience in the biopharmaceutical industry to the team.
Mr. Osterman held roles in sales, clinical, and marketing at GlaxoSmithKline before moving to Johnson & Johnson, where he launched their stem cell internal venture and was responsible for the cardiovascular, pulmonary, metabolic, and mimetibody therapeutic areas in the Global Biologic Strategic Marketing. Mr. Osterman then served as Senior Vice President responsible for commercial operations and business development at Discovery Labs before accepting a position as Vice President of Global Marketing at Solstice Neurosciences. Immediately prior to joining Kineticos, he founded the Osterman Strategy Group, a boutique management consulting firm, where he worked with large and emerging biopharmaceutical companies to help solve their most challenging business issues.
Mr. Osterman earned a dual BA in Business Management and Economics from North Carolina State University.
Mr. Osterman’s Areas of Expertise:
Global Strategic Marketing
New Business Development
Merger and Acquisition Strategy
Organizational and Leadership Development
Ms. Vaughan, Operating Executive of Kineticos’ Biopharmaceutical Practice, adds more than 22 years of experience in the biopharmaceutical industry to the team.
Ms. Vaughan’s experience spans the entire healthcare value chain culminating from roles in Quality, R&D, Technical Operations, Business Development, Alliance Management, Supply Chain & Commercial Operations. Stacey has a proven Business Development track record spanning big pharma to start-up organizations across all dose forms as well as devices. Her most recent work history expanded her experience in supply chain management and go-to-market strategies. As the head of Supply Chain at Putney, Stacey implemented and managed a wholly outsourced supply chain spanning raw materials through to end user product logistics and distribution. Most recently, Stacey was Director of Commercial Readiness at Mylan where she was responsible for evaluation, commercialization strategy and launch of acquired assets.
Stacey has held management roles at West Pharmaceutical Services, Cardinal Health PTS, Catalent, Putney and Mylan Pharmaceuticals. She earned a BA in Chemistry from Hiram College.
Ms. Vaughan’s Areas of Expertise:
Business Development & Licensing
New Product Planning
Mr. Dupere brings 30 years of experience in the biopharmaceutical industry to the Kineticos team. He spent 10 years immersed in formative training across core disciplines including clinical research, regulatory affairs, project, communications, and product management at both medical device (CTL, Inc.) and pharmaceuticals (Burroughs Wellcome Co.). He then started ATOM, Inc., a boutique consultancy focused on helping companies–including Lilly, Genentech, Sanofi and others—project manage the commercial launch their first oncology product. Mr. Dupere progressed to start new business units as Vice President of Business Development at LifeMetrix, retained consultant at US Oncology (Market Focus), and Sr. Vice President, Oncology Biopharmaceutical Solutions at Biologics, Inc. More recently, as COO for QOL Medical, he successfully re-positioned and built out an orphan disease company.
Mr. Dupere earned his BS in Public Health and MBA, both from the University of North Carolina at Chapel Hill.
Mr. Dupere’s Areas of Expertise:
Product Opportunity Assessment
Patient Access and Optimization
Mr. Hampton serves as Kineticos’ Vice President of Marketing brings over 10 years of sales and marketing of experience to the firm.
Mr. Hampton is responsible for coordinating and managing Kineticos’ thought leadership, brand awareness, and lead generation programs. Additionally, Mr. Hampton provides sales support to the sales function while maintaining an infrastructure that fosters growth. Mr. Hampton is also responsible for ensuring marketing objectives remain aligned with objectives of the firm and its practices.
Mr. Hampton earned his BS degree in Business Management with a Finance concentration from North Carolina State University in Raleigh, NC.
Mr. Hampton’s Areas of Expertise:
Thought Leadership Development
Contact Us Today to Discover How We Can Elevate Your Business Our Strategy Consulting Services Are Designed to Enhance Your Value